Finch Therapeutics Group, Inc. (FNCH)
OTCMKTS
· Delayed Price · Currency is USD
11.39
+0.14 (1.23%)
Feb 3, 2025, 12:19 PM EST
Finch Therapeutics Group Market Cap
Finch Therapeutics Group has a market cap or net worth of $18.47 million as of February 5, 2025. Its market cap has increased by 199.48% in one year.
Market Cap
18.47M
Enterprise Value
31.42M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$11.39
Market Cap Chart
Since March 19, 2021, Finch Therapeutics Group's market cap has decreased from 1.01B to 18.47M, a decrease of -98.16%. That is a compound annual growth rate of -64.26%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 4, 2025 | 18.47M | 1.77% |
| Dec 31, 2024 | 18.15M | 213.02% |
| Dec 29, 2023 | 5.80M | -74.79% |
| Dec 30, 2022 | 22.99M | -95.14% |
| Dec 31, 2021 | 473.36M | -52.91% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Endo Inc. | 2.13B |
| SS Innovations International | 1.45B |
| Veradigm | 807.06M |
| Elite Pharmaceuticals | 539.42M |
| Glass House Brands | 422.94M |
| Northwest Biotherapeutics | 375.11M |
| BioStem Technologies | 246.65M |
| Nika Pharmaceuticals | 246.33M |